Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

On a Limb: How Can We Better Optimize PAD Care?

Access Activity

Overview / Abstract:

Are your patients with PAD post-revascularization “on a limb”? Find out as Marc Bonaca, MD, MPH covers the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. This expert perspective provides clinicians with practical insights to apply to their practice.

The purpose of this activity is to provide learners with an engaging, practical presentation to help them optimize anticoagulant therapy in their patients with PAD post-revascularization. Learners post-activity will be better able to interpret the latest data on DOACs in PAD post-revascularization as well as optimize anticoagulant therapy for these patients.

Expiration

Jul 30, 2022

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

of .50 AMA PRA Category 1 Credit(s)

Accreditation

ACCME

Presenters / Authors / Faculty

Marc Bonaca, MD, MPH

Activity Specialities / Related Topics

Cardiology / Cardiovascular, Family Medicine, Internal Medicine, Primary Care

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Janssen Scientific Affairs, LLC.

Keywords / Search Terms

ACHL CME, CME/CE, Marc Bonaca, Bonaca, PAD, REACH, TRAP2-TIMI, MI, stroke, amputation, Acute Limb Ischemia, PEGASUS, EUCLID, AHA, ACC, clopidogrel, Dutch BOA, CASPAR, bleeding events, venous, DAPT, ePAD, Edoxaban, COMPASS, MALE, MACE, Rivaroxaban. Aspirin, VOYAGER, Ischemic Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map